此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

2013年9月19日 更新者:Lymphoma Trials Office

A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells. It is not yet known whether high dose chemotherapy plus bone marrow transplantation is more effective than high dose chemotherapy alone for intermediate- or high-grade non-Hodgkin's lymphoma.

PURPOSE: Randomized phase III trial to compare the effectiveness of high dose chemotherapy with or without bone marrow transplantation in treating patients who have intermediate- or high-grade non-Hodgkin's lymphoma.

研究概览

详细说明

OBJECTIVES: I. Assess the value of early intensification with autologous bone marrow transplantation or stem cell support in patients with poor prognosis intermediate or high grade non-Hodgkin's lymphoma.

OUTLINE: This is a randomized, multicenter study. Patients are stratified by age (under 50 vs 50 and over), bone marrow involvement (yes vs no), and country. All patients receive cyclophosphamide, doxorubicin, and vincristine on day 1 and prednisone on days 1-5. Courses repeat every 21 days. Patients receive a minimum of 6 courses of treatment in the absence of disease progression and unacceptable toxicity. Arm I: Patients receive carmustine IV over 2 hours on day 1 in week 9 or 10. Etoposide and cytarabine IV are administered over 30 minutes on days 2-5. Melphalan IV is administered over 5 minutes on day 6. Patients receive cryopreserved bone marrow or peripheral blood stem cells on day 7. Arm II: Patients continue conventional therapy. Patients are followed at 8-9 weeks and 6 months.

PROJECTED ACCRUAL: This study will accrue 500 patients.

研究类型

介入性

注册 (预期的)

500

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Aarhus、丹麦、DK 8000
        • Aarhus Amtssygehus
      • Copenhagen、丹麦、2100
        • Rigshospitalet
      • Oslo、挪威、N-0310
        • Norwegian Radium Hospital
      • Oslo、挪威、N-0407 4
        • Ullevall Hospital
      • Tromso、挪威、N-9037
        • University of Tromso
      • Prague (Praha)、捷克共和国、128 08
        • Charles University Hospital
      • Bournemouth、英国、BH7 7DW
        • Royal Bournemouth Hospital
      • Carluke UK、英国、ML8 5ER
        • Law Hospital
      • Chichester、英国、P019 4SE
        • Saint Richards Hospital
      • Enfield、英国、NG31 8DG
        • Chase Farm Hospital
      • Epsom Surrey、英国、KT19 7EG
        • Epsom General Hospital
      • Grantham、英国、NG31 8DG
        • Grantham and District Hospital
      • Ilford, Essex、英国、IG3 8YB
        • King George Hospital
      • King's Lynn、英国、PE30 4ET
        • Queen Elizabeth Hospital
      • Liverpool、英国、L9 1AE
        • Walton General Hospital
      • London、英国、W2 1NY
        • St. Mary's Hospital
      • London、英国、E13 8RU
        • Newham General Hospital
      • Middlesex、英国、N18 1QZ
        • West Middlesex Hospital
      • Redhill、英国、RH1 5RH
        • East Surrey Hospital
      • Rotherham、英国、S60 2UD
        • Rotherham District General Hospital-NHS Trust
      • Scunthorpe、英国、DN15 7BH
        • Scunthorpe General Hospital
      • Stafford、英国、ST16 3SA
        • Staffordshire General Hospital
    • England
      • Aylesbury-Buckinghamshire、England、英国、HP21 8AL
        • Stoke Mandeville Hospital
      • Bath、England、英国、BA1 3NG
        • Royal United Hospital
      • Birmingham、England、英国、B18 7QH
        • City Hospital - Birmingham
      • Birmingham、England、英国、B9 5SS
        • Birmingham Heartlands and Solihull NHS Trust (Teaching)
      • Bristol、England、英国、BS2 8ED
        • Bristol Haematology and Oncology Centre
      • Bristol、England、英国、BS10 5NB
        • Southmead Hospital
      • Burton-upon-Trent、England、英国、DE14 3QH
        • Queen's Hospital, Burton
      • Canterbury、England、英国、CT2 7NR
        • Kent and Canterbury Hospital
      • Cheltenham、England、英国、GL53 7AN
        • Cheltenham General Hospital
      • Chester、England、英国、CH2 1UL
        • Countess of Chester Hospital
      • Derby、England、英国、DE1 2QY
        • Derbyshire Royal Infirmary
      • Hampstead, London、England、英国、NW3 2QG
        • Royal Free Hospital
      • Harrow、England、英国、HA1 3UJ
        • Northwick Park Hospital
      • Huddersfield, West Yorks、England、英国、HD3 3EA
        • Huddersfield Royal Infirmary
      • Ipswich、England、英国、IP4 5PD
        • Ipswich Hospital NHS Trust
      • Leeds、England、英国、LS1 3EX
        • Leeds Teaching Hospital Trust
      • Leicester、England、英国、LE1 5WW
        • University Hospitals of Leicester
      • Liverpool、England、英国、L7 8XP
        • Royal Liverpool and Broadgreen Hospitals
      • London、England、英国、EC1A 7BE
        • Saint Bartholomew's Hospital
      • London、England、英国、SW17 ORE
        • St. Georges Hospital Medical School
      • London、England、英国、W6 8RF
        • Charing Cross Hospital
      • London、England、英国、E11 1NR
        • Whipps Cross Hospital
      • London、England、英国、WIT 3AA
        • Middlesex Hospital- Meyerstein Institute
      • London、England、英国、W1W 7EJ
        • University College London
      • London、England、英国、EC1A 7BE
        • St. Bartholomew's Hospital
      • London、England、英国、W1N 8AA
        • University College London Medical School
      • Maidstone、England、英国、ME16 9QQ
        • Maidstone Hospital
      • Manchester、England、英国、M20 4BX
        • Christie Hospital N.H.S. Trust
      • Merseyside、England、英国、L63 4JY
        • Clatterbridge Centre for Oncology NHS Trust
      • Merseyside、England、英国、PR8 6NJ
        • Southport and Formby District General Hospital
      • Milton Keynes、England、英国、MK6 5LD
        • Milton Keynes General Hospital
      • Northwood、England、英国、HA6 2RN
        • Mount Vernon Hospital
      • Nottingham、England、英国、NG5 1PB
        • Nottingham City Hospital NHS Trust
      • Oxford、England、英国、0X3 9DU
        • Oxford Radcliffe Hospital
      • Plymouth、England、英国、PL6 8DH
        • Derriford Hospital
      • Romford、England、英国、RM7 OBE
        • Oldchurch Hospital
      • Royal Tunbridge Wells, Kent、England、英国、TN2 4QJ
        • Pembury Hospital
      • Sheffield、England、英国、S1O 2SJ
        • Weston Park Hospital
      • Sheffield、England、英国、S1O 2JF
        • Sheffield Teaching Hospitals
      • Southampton、England、英国、SO14 0YG
        • Royal South Hants Hospital
      • Sutton、England、英国、SM2 5PT
        • Royal Marsden Hospital
      • Torquay Devon、England、英国、TQ2 7AA
        • Torbay Hospital
      • Uxbridge、England、英国、UB8 3NN
        • Hillingdon Hospital
      • West Bromwich、England、英国
        • Sandwell District General Hospital
      • West Midlands、England、英国、B75 7RR
        • Good Hope Hospital Trust
      • West Yorks、England、英国、WF8 1PL
        • Pontefract General Infirmary
      • Wolverhampton、England、英国、WV10 0QP
        • New Cross Hospital
    • Northern Ireland
      • Belfast、Northern Ireland、英国、BT9 7AB
        • Belfast City Hospital Trust
      • Londonderry、Northern Ireland、英国、BT47 1SB
        • Altnagelvin Area Hospital
    • Wales
      • Bangor、Wales、英国、LL57 2PW
        • Ysbyty Gwynedd

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

16年 至 65年 (孩子、成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

DISEASE CHARACTERISTICS: Histologically confirmed intermediate or high grade adult non-Hodgkin's lymphoma: Follicular large cell lymphoma Diffuse mixed cell lymphoma Diffuse large cell lymphoma Diffuse immunoblastic lymphoma Poor prognostic features defined as the presence of 2 or 3 of the following: Stage III/IV Lactase dehydrogenase greater than normal ECOG performance status 2-4 A new classification scheme for adult non-Hodgkin's lymphoma has been adopted by PDQ. The terminology of "indolent" or "aggressive" lymphoma will replace the former terminology of "low", "intermediate", or "high" grade lymphoma. However, this protocol uses the former terminology.

PATIENT CHARACTERISTICS: Age: 16 to 65 Performance status: See Disease Characteristics Life expectancy: Not specified Hematopoietic: Not specified Hepatic: See Disease Characteristics Renal: Not specified Other: No other medical condition prohibiting intensive therapy

PRIOR CONCURRENT THERAPY: At least 5 years since prior systemic therapy for cancer

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:David C. Linch、University College London Hospitals

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

1993年1月1日

研究注册日期

首次提交

1999年11月1日

首先提交符合 QC 标准的

2004年1月26日

首次发布 (估计)

2004年1月27日

研究记录更新

最后更新发布 (估计)

2013年9月20日

上次提交的符合 QC 标准的更新

2013年9月19日

最后验证

2007年5月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅